ArticleResearch square2026
Unveiling the Prevalence and Surgical Burden of Neurocristopathies: A Scoping Review and Statistical Analysis.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: The prevalence, clinical burden, impact on quality of life, and multidisciplinary treatment planning of Neurocristopathies (NCPs), disorders arising from aberrant development of neural crest cells (NCCs), remain obscure. NCCs are a pleistopotent embryonic stem cell population with diverse progeny of cell types ranging from craniofacial skeleton to cardiac outflow tract, peripheral nervous system, chromaffin cells, melanocytes etc. Given the broad range of neural crest derivatives, patients often present with complex, multisystem manifestations. However, these diverse symptoms may be overlooked, resulting in surgical planning that addresses only a single manifestation at a time rather than integrating the patient's full clinical presentation into treatment decisions. Methods: This scoping review with statistical analysis identified 92 distinct NCPs to quantify prevalence, anatomical defect patterns, cell type of origin and surgical management needs across craniofacial and non-craniofacial phenotypes. Results: When scaled to global birth statistics, NCPs accounted for ~4.24% of all live births, indicating that more than half (61%) of serious congenital anomalies are neurocristopathy in origin, greatly exceeding prior estimates. These primarily consisted of craniofacial, conotruncal, and peripheral nervous system defects. Plastic and reconstructive surgery (PRS) (which significantly overlap in procedures of Oral & Maxillofacial Surgery in the Craniofacial complex) emerged as a central clinical modality: 61 NCPs (66.3%) required PRS/OMFS, and nearly 100% of craniofacial bone and cartilage anomalies required functional reconstruction. Mandibular reconstruction (37%) and cleft lip/palate repair (37%) represented the most common interventions, with midface advancement, ear reconstruction, and cranial vault remodeling also frequently required. Chi-square analysis demonstrated a strong association between anatomical category and likelihood of PRS intervention (χ Conclusions: These findings establish NCPs as a major, underrecognized driver of congenital disease burden and demonstrate the critical role of PRS in restoring function and form across neurocristopathy phenotypes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.